VTVT Projected Dividend Yield
vTv Therapeutics Inc ( NASDAQ : VTVT )vTv Therapeutics is a holding company. Through its subsidiary, vTv Therapeutics LLC, Co. is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for diabetes. Co. has a pipeline of small molecule clinical and pre-clinical drug candidates. Co.'s primary program is TTP399, an orally administered, small molecule, liver-selective glucokinase activator for the treatment of type 1 diabetes. In addition to the studies of TTP399, Co. is conducting a Phase 1 mechanistic study of TTP399 in patients with type 1 diabetes to determine the impact of TTP399 on ketone body formation during a period of acute insulin withdrawal. 20 YEAR PERFORMANCE RESULTS |
VTVT Dividend History Detail VTVT Dividend News VTVT Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |